High EIF4EBP1 expression reflects mTOR pathway activity and cancer cell proliferation and is a biomarker for poor breast cancer prognosis.
Article in American Journal of Cancer Research (January 2024)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Article in American Journal of Cancer Research (January 2024)
Article in International Journal of Molecular Sciences (July 2023)
Article in Cell Death Discovery (March 2023)